Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Female Health FHCO -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (72)	10/9/2014 12:56:05 AM
From: Savant	Respond to of 211

Makes the case for more FHCO female condoms... ebola in semen..'up to' 3+ months How Long Does the Ebola Virus Survive in Semen? Research shows the virus can be found in survivors' semen for weeks or months after recovery. —By Alex Park \| Wed Oct. 8, 2014 12:32 PM EDT Survivors of Ebola often face stigma and fear from community members who worry they might spread the disease after leaving the hospital. These fears are almost entirely misplaced. Once someone has recovered from the virus, they cannot infect others through handshakes, hugs, or kisses. Their sweat isn't contagious. Even the vomit, urine, and feces of the disease's survivors has been shown to be Ebola free. There are, however, a couple important exceptions. In particular, research into past outbreaks shows that the semen of survivors may carry the virus for weeks, or even months, after they recover. For instance, a 1977 study of an outbreak in what is now the Democratic Republic of Congo found Ebola in the semen of one survivor 61 days after the onset of his disease. And a 1999 study found the virus in an Ebola survivor's semen 82 days after he first became ill. That study recommended that survivors use condoms for "at least" three months after contracting the disease. A separate 1999 study, backed by the Centers for Disease Control, identified one woman who tested positive for Ebola but never developed symptoms. The researchers concluded that it was unclear if she ever actually contracted the virus, but that it was "possible" that she was infected by a recovered Ebola patient via his semen. In a statement issued Monday, the World Health Organization echoed these findings, warning that Ebola "can persist in [survivors'] semen for at least 70 days" and that some research even "suggests persistence for more than 90 days." The sample sizes for these studies are extremely small, and it's unclear just how great a risk the semen of surviving men poses in the weeks following their illness. Still, officials from the Centers for Disease Control and Prevention have recommended that they use condoms. And Doctors Without Borders—which has been on the front lines of the current outbreak since its early stages—is distributing condoms to survivors, according to a spokesperson for the group. Speaking at a United Nations office in Liberia earlier this month, an epidemiologist and WHO consultant from Uganda—a nation that saw its own Ebola outbreak as recently as 2013—said that sexual transmission could make the disease harder to contain. He criticized public health officials for not doing enough to encourage the use of condoms. And Semen may not be the only bodily fluid through which a patient recovering from Ebola could pass on the disease. In 2000, researchers tested the fluids of a female Ebola survivor whose blood was already clear of the virus. Fifteen days after first falling ill, Ebola was still found in the woman's breast milk. Her child eventually died of Ebola, though the researchers could not be certain the child got sick from feeding. "At any rate," wrote the researchers, "it seems prudent to advise breastfeeding mothers who survive [Ebola] to avoid breastfeeding for at least some weeks after recovery." motherjones.com

To: Glenn Petersen who wrote (72)	12/9/2014 3:52:37 AM
From: Savant	Respond to of 211

SA piece about FHCO, fwiw seekingalpha.com

To: Glenn Petersen who wrote (72)	1/26/2015 10:17:03 AM
From: Savant	Respond to of 211

The Female Health Company Receives Orders for 25 Million FC2 from Brazil 7:30 AM ET 1/26/15 \| PR Newswire The Female Health Company (NASDAQ-CM: FHCO) today announced that, its exclusive distributor in Brazil, Semina Industria e Comercio Ltda has placed orders for 25 million FC2 Female Condoms. photos.prnewswire.com "These orders have been received in fulfillment of the Brazilian Ministry of Health tender awarded in 2014," noted Karen King, President and Chief Executive Officer of The Female Health Company. "By mid-December, we had already produced and shipped over 5 million units and we anticipate the majority of the units under these orders to ship in FHC's fiscal Q2, between January and March 2015." "Once again, I would like to point to the global leadership Brazil has demonstrated with its exemplary HIV/AIDS prevention program and a strong commitment to empowering women to take control of their health and wellness. We are pleased to be contributing to their successful program through our training and education efforts in country and through supply of FC2, a critical tool for women in protecting against sexually-transmitted diseases and unwanted pregnancies." About The Female Health Company The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom(R) (FC2). Since the Company began distributing FC2 in 2007, it has been shipped to 144 countries. The Company owns certain worldwide rights to the FC2 Female Condom(R), including patents that have been issued in a number of countries around the world. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The FC2 Female Condom(R) is the only currently available female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies. "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: